Related Experiment Video
Updated: May 5, 2026

The Modular Design and Production of an Intelligent Robot Based on a Closed-Loop Control Strategy
Published on: October 14, 2017
Integrating AI into next-generation PROTAC Engineering: a comprehensive toolkit for rational PROTAC design
Pitam Ghosh1, Ryena Dhir1, Dinki Sharma1
1Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Artificial intelligence is revolutionizing Proteolysis Targeting Chimeras (PROTACs) by enabling the design of novel protein degraders. AI tools address limitations in conventional methods, improving drug discovery for previously undruggable targets.
Area of Science:
- Biochemistry and Medicinal Chemistry
- Drug Discovery and Development
- Computational Chemistry
Background:
- Proteolysis Targeting Chimeras (PROTACs) are bifunctional molecules that induce targeted protein degradation.
- PROTACs offer an event-driven mechanism for degrading disease-associated proteins, overcoming limitations of traditional inhibitors.
- Challenges including poor pharmacokinetics and high molecular weight hinder PROTAC clinical application.
Purpose of the Study:
- To review the limitations of conventional computational methods in PROTAC research.
- To explore emerging AI-driven tools for various aspects of PROTAC development.
- To highlight current challenges and future directions in AI-assisted PROTAC design.
Main Methods:
- Review of existing literature on computational methods and AI applications in PROTAC research.
- Identification and categorization of AI tools for target selection, linker generation, activity prediction, degradability assessment, ternary complex modeling, PROTAC generation, and ADME property estimation.
- Analysis of challenges associated with AI in PROTAC development.
Main Results:
- AI-driven technologies are being utilized to generate novel, chemically valid PROTACs, overcoming limitations of traditional methods.
- Specific AI tools demonstrate potential in target selection (DeepUSI, DrugnomeAI), linker generation (AIMLinker, DiffLinker), activity prediction (AI-DPAPT, DeepPROTAC), and more.
- AI accelerates the design and optimization of PROTACs for improved therapeutic potential.
Conclusions:
- AI significantly enhances PROTAC research, offering solutions to challenges in drug discovery and development.
- Addressing data scarcity, reproducibility, and model generalizability is crucial for advancing AI in PROTACs.
- Hybrid or integrated AI approaches are needed to overcome current limitations and fully realize the potential of AI-driven PROTAC design.
Related Concept Videos
PI Controller: Design
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Properties of the z-Transform I
Control Systems
At the heart...
Design Consideration
The factor of safety is another key...
Time and frequency -Domain Interpretation of PI Control
Acting as a low-pass filter, the PI controller slows the system's response and extends settling times. This requires...

